A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives

Triple-negative breast cancer (TNBC), accounting for 10–15% of all breast malignancies, is more prevalent in women under 40, particularly in those of African descent or carrying the BRCA1 mutation. TNBC is characterized by the absence of estrogen and progesterone receptors (ER, PR) and low or elevat...

Descripción completa

Detalles Bibliográficos
Autores principales: Akash, Shopnil, Aovi, Farjana Islam, Azad, Md. A. K., Kumer, Ajoy, Chakma, Unesco, Islam, Md. Rezaul, Mukerjee, Nobendu, Rahman, Md. Mominur, Bayıl, Imren, Rashid, Summya, Sharma, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569544/
https://www.ncbi.nlm.nih.gov/pubmed/37824496
http://dx.doi.org/10.1371/journal.pone.0283271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569544/
https://www.ncbi.nlm.nih.gov/pubmed/37824496
http://dx.doi.org/10.1371/journal.pone.0283271

Ejemplares similares